MIT Zuid R&D subsidy for new partnership with ShanX Medtech

MIT Zuid R&D subsidie voor nieuwe samenwerking met ShanX Medtech

 We are very happy to announce that, together with ShanX Medtech BV, our project to develop a rapid diagnostic tool for Urinary Tract Infection (UTI) patients aimed at combating antibiotic resistance has been granted a MIT Zuid R&D subsidy by Stimulus Programmamanagement. 

UTIs are among the most common infections in the human body and they account for a large part of visits to the Dutch GP practice. The current way to diagnose a UTI has low sensitivity and results to the prescription of unnecessary antibiotics. 

ShanX Medtech and Omnigen will combine forces to develop a platform to detect a UTI and its causative pathogen. 

Share This Story, Choose Your Platform!

Work together with Omnigen?

Then please contact us!
Known for, among others:
Known for, among others